Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Moderna Inc (NQ: MRNA )

82.30 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 6, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,795
Open 82.30
Bid (Size) 83.25 (1)
Ask (Size) 83.54 (5)
Prev. Close 82.30
Today's Range 82.30 - 82.30
52wk Range 62.55 - 170.47
Shares Outstanding 384,000,000
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
$1000 Invested In This Stock 5 Years Ago Would Be Worth $6,300 Today
Via Benzinga
3 Undervalued Stocks With Room to Rally Even Higher
The latest market sell-off could be a great time to give the slate of undervalued stocks another look before tech reverses course. 
Via InvestorPlace

Performance

YTD
-26.84%
-26.84%
1 Month
-29.33%
-29.33%
3 Month
-32.02%
-32.02%
6 Month
-17.72%
-17.72%
1 Year
-18.68%
-18.68%

More News

Read More
Moderna Lost 27% Of Its Value Over Two Days. It Just Crumbled Again.
Via Investor's Business Daily
Home Depot To Rally More Than 14%? Here Are 10 Top Analyst Forecasts For Monday
Via Benzinga
BioNTech's Q2 Loss Widens Amid Low Demand For Its Pfizer-Partnered COVID-19 Vaccine, Increases R&D Spending On New Cancer Products
Via Benzinga
Exposures COVID-19
Moderna's Ongoing Decline
Via Talk Markets
Moderna Reports Second Quarter 2024 Financial Results and Provides Business Updates
Via ACCESSWIRE
Here's How Much You Would Have Made Owning Moderna Stock In The Last 5 Years
Via Benzinga
MicroStrategy, Intel And Moderna Are Among Top 12 Large Cap Losers Last Week (July 28-August 3): Are The Others In Your Portfolio?
Via Benzinga
Cathie Wood Bought This Stock After Its 27% Drop. Should You?
Via The Motley Fool
Where Will Novavax Be in 5 Years?
Via The Motley Fool
Moderna Stock Trading Lower On Dismal Guidance, Analysts Cuts Price Targets Noting Competitive Pressure From GSK, Pfizer
Via Benzinga
Exposures COVID-19
Stock Market Takes Bearish Turn; Apple, Microsoft, Meta, Amazon, AMD In Focus: Weekly Review
Via Investor's Business Daily
Topics Artificial Intelligence
Exposures Artificial Intelligence
Cathie Wood's Ark Adds Over $19M Worth Of Moderna Shares After Thursday's 21% Plunge On Guidance Cut
Via Benzinga
3 AI-Powered Healthcare Stocks Transforming Medicine
Via InvestorPlace
Topics Artificial Intelligence
Exposures Artificial Intelligence
US Stocks Close Lower As Apple, Amazon Report Earnings: Greed Index Moves To 'Fear' Zone
Via Benzinga
Topics Stocks
Exposures US Equities
MRNA Investors Have Opportunity to Join Moderna, Inc. Fraud Investigation with the Schall Law Firm
From The Schall Law Firm
Via Business Wire
Crude Oil Moves Lower; Moderna Shares Plunge
Via Benzinga
Exposures Fossil Fuels
Stock Of The Day: Moderna Stock Plunges, Breaking Key Support Levels Following Earnings Report
Via Benzinga
Moderna (MRNA) Q2 2024 Earnings Call Transcript
Via The Motley Fool
Topics Earnings
Exposures Financial
Stocks To Watch Today: MRNA, META, And AMAT
Via Talk Markets
Topics Artificial Intelligence
Exposures Artificial Intelligence
Moderna CEO Stephane Bancel On Q2 Results, Slashing Its Full-Year Sales Guidance
Via Talk Markets
Moderna Stock Sinks On Lowered 2024 Outlook, Cites Low European Sales, Competitive RSV Vaccine Market
Via Benzinga
Exposures COVID-19
Moderna Slashes Its Outlook On 'Very Low' European Sales Despite Quarterly Beat
Via Investor's Business Daily
Get Your Money Out of These 3 Biotech Stocks Before the End of July
Via InvestorPlace
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.